SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-18-018327
Filing Date
2018-03-30
Accepted
2018-03-30 17:25:29
Documents
76
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A tv481830_10qa.htm 10-Q/A 364746
2 EXHIBIT 31.1 tv481830_ex31-1.htm EX-31.1 8246
3 EXHIBIT 31.2 tv481830_ex31-2.htm EX-31.2 8323
4 EXHIBIT 32.1 tv481830_ex32-1.htm EX-32.1 3981
5 EXHIBIT 32.2 tv481830_ex32-2.htm EX-32.2 3915
  Complete submission text file 0001144204-18-018327.txt   4867704

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT xtnt-20170331.xml EX-101.INS 998327
7 XBRL TAXONOMY EXTENSION SCHEMA xtnt-20170331.xsd EX-101.SCH 56675
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xtnt-20170331_cal.xml EX-101.CAL 57269
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xtnt-20170331_def.xml EX-101.DEF 368200
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE xtnt-20170331_lab.xml EX-101.LAB 414322
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xtnt-20170331_pre.xml EX-101.PRE 409604
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-34951 | Film No.: 18726698
SIC: 2836 Biological Products, (No Diagnostic Substances)